1. Viganò, Silvana, D'Andrea, Giovanna, Valle, Patrizia Della, Margaglione, Maurizio, D'Angelo, Armando. 2018. A novel allele variant of the SERPINF2 gene responsible for severe plasmin inhibitor (α2-antiplasmin) deficiency in an Italian patient. In Thrombosis research, 166, 60-62. doi:10.1016/j.thromres.2018.04.006. https://pubmed.ncbi.nlm.nih.gov/29656168/
2. Hagemann, Christoffer A, Legart, Christian, Møllerhøj, Mathias B, Jelsing, Jacob, Knop, Filip K. 2022. A liver secretome gene signature-based approach for determining circulating biomarkers of NAFLD severity. In PloS one, 17, e0275901. doi:10.1371/journal.pone.0275901. https://pubmed.ncbi.nlm.nih.gov/36260611/
3. Hou, Miaomiao. . Exploring novel independent prognostic biomarkers for hepatocellular carcinoma based on TCGA and GEO databases. In Medicine, 101, e31376. doi:10.1097/MD.0000000000031376. https://pubmed.ncbi.nlm.nih.gov/36316888/
4. Barrón-Gallardo, Carlos A, Garcia-Chagollán, Mariel, Morán-Mendoza, Andres J, Aguilar-Lemarroy, Adriana, Jave-Suárez, Luis F. 2022. A gene expression signature in HER2+ breast cancer patients related to neoadjuvant chemotherapy resistance, overall survival, and disease-free survival. In Frontiers in genetics, 13, 991706. doi:10.3389/fgene.2022.991706. https://pubmed.ncbi.nlm.nih.gov/36338974/
5. Asselbergs, Folkert W, Guo, Yiran, van Iperen, Erik P A, Keating, Brendan J, Drenos, Fotios. 2012. Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci. In American journal of human genetics, 91, 823-38. doi:10.1016/j.ajhg.2012.08.032. https://pubmed.ncbi.nlm.nih.gov/23063622/